Fetal Hemoglobin Modulation in Sickle Cell Disease: βs Haplotypes, Key Polymorphisms Identified by GWAS, and Advances in γ-Globin Editing: An Updated Overview
Genes · 2026
DOI: 10.3390/genes17020135 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2026. Verfasst von Yusselfy Márquez-Benitez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program in Biosciences, Faculty of Engineering, Universidad de La Sabana, Campus del Puente del Común, Km 7 Autopista Norte de Bogotá, Chía …. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Fetal Hemoglobin, gamma-Globins, Gene Editing. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de La Sabana.
Abstract (Originalsprache)
Fetal hemoglobin (HbF) plays a central role in mitigating the pathophysiological effects of sickle cell disease (SCD). Understanding the genetic determinants influencing HbF expression is essential for identifying the factors contributing to its modulation. This review provides an updated synthesis of evidence on HbF modulation, focusing on βs haplotypes and their molecular characterization through Sanger sequencing, polymorphisms consistently associated with HbF levels in genome-wide association studies (GWAS), and recent advances in gene editing targeting HbF expression. An integrative review (2016–2025) was conducted using PubMed/MEDLINE, Scopus, and Web of Science, encompassing original research, experimental studies, systematic reviews, and genomic analyses. Key regulatory loci such as BCL11A, HBS1L-MYB (HMIP), and the HBB cluster explain a significant proportion of HbF variability across populations. Furthermore, additional variants in KLF1, NFIX, BACH2, and ZBTB7A have emerged as potential modulators in specific cohorts. Regarding advances in γ-globin editing, “prime editing”, although still in the experimental phase, has recently emerged as an innovative approach capable of introducing multiple HPFH-like mutations within γ-globin promoters, expanding future therapeutic possibilities in SCD. This review also provides a comparative overview of prime editing and other gene-editing strategies for HbF modulation, such as CRISPR-Cas9 and Base editing. Collectively, this work outlines the current landscape of HbF modulation and provides an informative basis for future research aimed at advancing precision-oriented therapeutic strategies in sickle cell disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral Program in Biosciences, Faculty of Engineering, Universidad de La Sabana, Campus del Puente del Común, Km 7 Autopista Norte de Bogotá, Chía 250001, Cundinamarca, Colombia.
- Human Genetics Research Group, Faculty of Medicine, Universidad de La Sabana, Campus del Puente del Común, Km 7 Autopista Norte de Bogotá, Chía 250001, Cundinamarca, Colombia.
- Faculty of Health Sciences, Universidad del Sinú Elías Bechara Zainum, Transversal 54 #41-117, Cartagena 130001, Bolívar, Colombia.
ORCID-Profile: Yusselfy Márquez-Benitez, Valeria Isabela Osorio-Garzón, Jaime Eduardo Bernal-Villegas, Ignacio Briceño-Balcázar
Förderung
- Universidad de La Sabana
Zitieren
APA
Márquez-Benitez, Y., Osorio-Garzón, V. I., Bernal-Villegas, J. E., & Briceño-Balcázar, I. (2026). Fetal Hemoglobin Modulation in Sickle Cell Disease: βs Haplotypes, Key Polymorphisms Identified by GWAS, and Advances in γ-Globin Editing: An Updated Overview. Genes. https://doi.org/10.3390/genes17020135
Vancouver
Márquez-Benitez Y, Osorio-Garzón VI, Bernal-Villegas JE, Briceño-Balcázar I. Fetal Hemoglobin Modulation in Sickle Cell Disease: βs Haplotypes, Key Polymorphisms Identified by GWAS, and Advances in γ-Globin Editing: An Updated Overview. Genes. 2026. doi:10.3390/genes17020135
BibTeX
@article{MrquezBenitez2026,
author = {Márquez-Benitez, Yusselfy and Osorio-Garzón, Valeria Isabela and Bernal-Villegas, Jaime Eduardo and Briceño-Balcázar, Ignacio},
title = {Fetal Hemoglobin Modulation in Sickle Cell Disease: βs Haplotypes, Key Polymorphisms Identified by GWAS, and Advances in γ-Globin Editing: An Updated Overview},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17020135}
}
EUVIMED